Etodolac Tablet, Film Coated, Extended Release
NDC Package 0093-1122-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Etodolac tablets is etodolac is used to relieve pain from various conditions. This formulation utilizes a tablet, film coated, extended release delivery system. Marketed by Teva Pharmaceuticals Usa, Inc., this product is identified by NDC 0093-1122 and is authorized under FDA application ANDA075665.

Identification & Billing

NDC Package Code
0093-1122-01
Package Description
100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE
Product Code
0093-1122
11-Digit Billing Format
00093112201
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
100 EA
RxNorm Crosswalk
  • RxCUI: 310245 - etodolac 400 MG 24HR Extended Release Oral Tablet
  • RxCUI: 310245 - 24 HR etodolac 400 MG Extended Release Oral Tablet
  • RxCUI: 310245 - etodolac 400 MG 24 HR Extended Release Oral Tablet
  • RxCUI: 310247 - etodolac 600 MG 24HR Extended Release Oral Tablet
  • RxCUI: 310247 - 24 HR etodolac 600 MG Extended Release Oral Tablet

Clinical Specifications

Proprietary Name
Etodolac
Non-Proprietary Name
Etodolac
Substance Name
Etodolac
Dosage Form
Tablet, Film Coated, Extended Release - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer; the tablet is formulated in such manner as to make the contained medicament available over an extended period of time following ingestion.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
ETODOLAC 400 mg/1
Pharmacologic Class
Usage Information
Etodolac is used to relieve pain from various conditions. It also reduces pain, swelling, and joint stiffness from arthritis. This medication is known as a nonsteroidal anti-inflammatory drug (NSAID). It works by blocking your body's production of certain natural substances that cause inflammation. If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain. See also Warning section.

Regulatory & Marketing

Labeler Name
Teva Pharmaceuticals Usa, Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA075665
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
02-09-2001
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0093-1122-01 identifies a specific commercial package of 100 tablet, film coated, extended release in 1 bottle of Etodolac, a human prescription drug labeled by Teva Pharmaceuticals Usa, Inc.. This tablet, film coated, extended release is formulated for oral use and contains etodolac as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Teva Pharmaceuticals Usa, Inc. on February 09, 2001. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Etodolac is used to relieve pain from various conditions. It also reduces pain, swelling, and joint stiffness from arthritis. This medication is known as a nonsteroidal anti-inflammatory drug (NSAID). It works by blocking your body's production of certain natural substances that cause inflammation. If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain. See also Warning section.

How is this Teva Pharmaceuticals Usa, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00093112201. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0093-1122-01
11-Digit CMS (5-4-2)
00093-1122-01

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.